Gavin Pharaoh’s current role is as a scientist in preclinical development at Gordian Biotechnology working on gene therapies for age-related diseases including heart failure. His academic research focused on the role of mitochondria in aging and disease integrating physiological, pharmaceutical, genetic, molecular, and mitochondrial bioenergetic techniques.